William Barchuk

1.2k citations

22 papers · 677 indexed · h-index 10

Impact in

Applied Microbiology and Biotechnology top 5%
- Antibiotic Use and Resistance
Critical Care and Intensive Care Medicine top 5%
- Intensive Care Unit Cognitive Disorders
- Nosocomial Infections in ICU

Papers in ⓘ

Rheumatology 10
- Rheumatoid Arthritis Research and Therapies 6
- Spondyloarthritis Studies and Treatments 5
- Urticaria and Related Conditions 2
Hepatology 4
- Liver Diseases and Immunity 4

Co-authors: Leah Teoh (3 shared papers)Edward A. Panacek (2 shared papers)Mark Miller (2 shared papers)Rodger D. MacArthur (2 shared papers)Timothy Albertson (1 shared paper)David H. Johnson (1 shared paper)Steven Fischkoff (2 shared papers)Stanley Lemeshow (1 shared paper)
Journals: Annals of the Rheumatic Diseases (6 papers)Lara D. Veeken (2 papers)Journal of Hepatology (2 papers)Clinical Infectious Diseases (1 paper)Inflammation Research (1 paper)
Partner nations: United States Canada Belgium

In The Last Decade

William Barchuk

21 papers receiving 661 citations

Peers

Countries citing papers authored by William Barchuk

Since Specialization

Citations

This map shows the geographic impact of William Barchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Barchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Barchuk more than expected).

Fields of papers citing papers by William Barchuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Barchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Barchuk. The network helps show where William Barchuk may publish in the future.

Co-authors

The 25 scholars most cited alongside William Barchuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William Barchuk Line = papers co-authored together William Barchuk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels* Critical Care Medicine ·Edward A. Panacek, John C. Marshall, Timothy E. Albertson, David H. Johnson, Steven B. Johnson, Rodger D. MacArthur, Mark Miller, William Barchuk, Steven Fischkoff, Martin Kaul, Leah Teoh, Lori Van Meter, Lothar Daum, Stanley Lemeshow, Gregory A. Hicklin, Christopher J. Doig	2004	267
2	Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial Clinical Infectious Diseases ·Rodger D. MacArthur, Mark Miller, Timothy Albertson, Edward A. Panacek, David H. Johnson, Leah Teoh, William Barchuk	2004	196
3	A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome Intensive Care Medicine ·James J. Gallagher, Charles J. Fisher, Bruce W. Sherman, Mark Munger, Brandon M. Meyers, Travis Ellison, Steven Fischkoff, William Barchuk, Leah Teoh, Raja Velagapudi	2001	35
4	A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion Journal of Allergy and Clinical Immunology ·William Barchuk, Anne Marie Salapatek, Tingting Ge, Pina D’Angelo, Xuejun Liu	2013	24
5	OP0218 Efficacy and safety results of guselkumab, an anti-il23 monoclonal antibody, in patients with active psoriatic arthritis over 24 weeks: a phase 2a, randomized, double-blind, placebo-controlled study Annals of the Rheumatic Diseases ·Atul Deodhar, Alice B. Gottlieb, Wolf‐Henning Boehncke, Bo Dong, Y Wang, William Barchuk, X-L Xu, Elizabeth C. Hsia	2017	22
6	Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial) Lara D. Veeken ·Walter P. Maksymowych, Mikkel Østergaard, Robert Landewé, William Barchuk, Ke Liu, Chantal Tasset, Leen Gilles, Thijs Hendrikx, R. Besuyen, Xenofon Baraliakos	2021	19
7	Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma Pulmonary Pharmacology & Therapeutics ·William Barchuk, John M. Lambert, Rainard Fuhr, Joel Jiang, K Bertelsen, A Fourie, X. Liu, Philip E. Silkoff, Elliot S. Barnathan, Robin L. Thurmond	2014	18
8	Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial Lara D. Veeken ·Walter P. Maksymowych, Mikkel Østergaard, Robert Landewé, William Barchuk, Ke Liu, Leen Gilles, Thijs Hendrikx, R. Besuyen, Xenofon Baraliakos	2021	16
9	Safety and Efficacy of Poseltinib, Bruton’s Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study The Journal of Rheumatology ·Mark C. Genovese, Alberto Spindler, Akira Sagawa, Won Park, Anna Dudek, Alan Kivitz, Jeannie Chao, Lai Shan Chan, Jennifer Witcher, William Barchuk, Ajay Nirula	2020	15
10	Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study Inflammation Research ·David L. Boyle, Samuel E. DePrimo, César A. Calderón, Dion Chen, Paul J. Dunford, William Barchuk, Gary S. Firestein, Robin L. Thurmond	2019	9
11	REGULATION OF CLL BY INTERLEUKIN-10 - ROLE OF ANTISENSE IL-10 Oncology Reports ·Helen Fernandes, William Barchuk, Gustavo Vicentis Oliveira Fernandes, Sumant Ramachandra, CC CHOU, Elizabeth Raveché	1995	9
12	OP0308 Efficacy and safety results of guselkumab in patients with active psoriatic arthritis over 56 weeks from a phase 2a, randomised, double-blind, placebo-controlled study Annals of the Rheumatic Diseases ·Atul Deodhar, Alice B. Gottlieb, Wolf‐Henning Boehncke, Bo Dong, Y. Wang, Yanli Zhuang, William Barchuk, X. L. Xu, Elizabeth C. Hsia	2018	9
13	Chronic angio-oedema of the tongue associated with pernicious anaemia and Hashimoto's thyroiditis Clinical and Experimental Dermatology ·Sandra Piltz, William Barchuk, John Oppenheimer, Howard M. Druce, Leonard Bielory	1995	9
14	A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS) Journal of Hepatology ·Michael Trauner, Cynthia Levy, Atsushi Tanaka, Zachary Goodman, Douglas Thorburn, Deepak Joshi, Kimmo Salminen, Kidist Yimam, Hiroyuki Isayama, Aldo J. Montaño‐Loza, Mark Danta, Holger Hinrichsen, Pietro Invernizzi, Xiangyu Liu, Xiaomin Lu, Muhsen Al-ani, William Barchuk, Timothy R. Watkins, Mark C. Genovese, Christopher L. Bowlus	2023	8
15	Filgotinib in Active Noninfectious Uveitis JAMA Ophthalmology ·Sunil K. Srivastava, Timothy R. Watkins, Quan Dong Nguyen, Sumit Sharma, David K. Scales, Mark Dacey, Rajiv Shah, David Chu, Dilraj S. Grewal, J. Lisa, Eric B. Suhler, Mark C. Genovese, Ying Guo, William Barchuk, R. Besuyen, Andrew D. Dick, James T. Rosenbaum	2024	7
16	Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis Hepatology Communications ·Douglas Thorburn, Diana Julie Leeming, William Barchuk, Ya Wang, Xiaomin Lu, Vladislav A. Malkov, Kaori Ito, Christopher L. Bowlus, Cynthia Levy, Zachary Goodman, M.A. Karsdal, Andrew J. Muir, Jun Xu	2024	5
17	THU0377 IMPACT OF FILGOTINIB ON STRUCTURAL LESIONS IN THE SACROILIAC JOINTS AT 12 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: MAGNETIC RESONANCE IMAGING DATA FROM THE DOUBLE-BLIND, RANDOMIZED TORTUGA TRIAL Annals of the Rheumatic Diseases ·Walter P. Maksymowych, Mikkel Østergaard, R. B. M. Landewé, William Barchuk, K. Liu, Chantal Tasset, L. Gilles, Thijs Hendrikx, R. Besuyen, Xenofon Baraliakos	2020	4
18	SAT0089 SAFETY AND EFFICACY OF LY3337641, A BRUTON'S TYROSINE KINASE INHIBITOR IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-PART PHASE 2 STUDY Annals of the Rheumatic Diseases ·Mark C. Genovese, Alberto Spindler, Akira Sagawa, Won Park, Anna Dudek, Alan Kivitz, Jeannie Chao, William Barchuk, Ajay Nirula	2019	2
19	Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study Clinical and Translational Gastroenterology ·Cynthia Levy, Stephen H. Caldwell, Parvez Mantry, Velimir A. Luketic, Charles Landis, Jonathan Huang, Edward Mena, Rahul Maheshwari, Kevin Rank, Jun Xu, Vladislav A. Malkov, Andrew N. Billin, Xiangyu Liu, Xiaomin Lu, William Barchuk, Timothy R. Watkins, Chuhan Chung, Robert P. Myers, Kris V. Kowdley	2024	1
20	OP0141 EFFECTS OF FILGOTINIB ON SPINAL LESIONS IN ANKYLOSING SPONDYLITIS: MAGNETIC RESONANCE IMAGING DATA FROM THE TORTUGA TRIAL Annals of the Rheumatic Diseases ·Xenofon Baraliakos, Mikkel Østergaard, R. B. M. Landewé, William Barchuk, K. Liu, Chantal Tasset, L. Gilles, Thijs Hendrikx, R. Besuyen, Walter P. Maksymowych	2021	1

About William Barchuk

William Barchuk is a scholar working on Rheumatology, Hepatology, Applied Microbiology and Biotechnology, Genetics and Immunology, having authored 22 papers that have together received 677 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Spondyloarthritis Studies and Treatments (5 papers), Liver Diseases and Immunity (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Sepsis Diagnosis and Treatment (3 papers) and Urticaria and Related Conditions (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (53 citations), Critical Care and Intensive Care Medicine (112 citations), Immunology (220 citations), Clinical Biochemistry (70 citations) and Epidemiology (348 citations). William Barchuk has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Leah Teoh, Edward A. Panacek, Mark Miller, Rodger D. MacArthur, Timothy Albertson, David H. Johnson, Steven Fischkoff, Stanley Lemeshow, Steven B. Johnson and Martin Kaul. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Journal of Hepatology, Clinical Infectious Diseases and Inflammation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact